GSKIP
Basic information
Region (hg38): 14:96363452-96387288
Previous symbols: [ "C14orf129" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSKIP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 4 | |||||
Total | 0 | 0 | 8 | 0 | 4 |
Variants in GSKIP
This is a list of pathogenic ClinVar variants found in the GSKIP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-96363513-G-T | Benign (Jul 25, 2019) | |||
14-96363661-G-A | Benign (Apr 01, 2020) | |||
14-96382140-T-C | Benign (Jul 10, 2018) | |||
14-96382228-CTTT-C | GSKIP-related disorder | Likely benign (Dec 16, 2019) | ||
14-96382228-C-CT | Benign (Dec 05, 2020) | |||
14-96382280-C-A | not specified | Uncertain significance (Jan 11, 2023) | ||
14-96382281-A-G | not specified | Uncertain significance (Jan 11, 2023) | ||
14-96382329-A-T | not specified | Uncertain significance (Nov 22, 2022) | ||
14-96382353-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
14-96382376-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
14-96382419-C-T | not specified | Uncertain significance (May 28, 2024) | ||
14-96382429-A-C | not specified | Uncertain significance (Feb 15, 2023) | ||
14-96382469-C-G | not specified | Uncertain significance (Feb 22, 2023) | ||
14-96382562-A-G | Benign (Jul 09, 2018) | |||
14-96385566-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
14-96385620-G-A | not specified | Uncertain significance (Dec 03, 2024) | ||
14-96385637-G-A | not specified | Uncertain significance (Aug 27, 2024) | ||
14-96385673-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
14-96385734-T-C | Benign (Jul 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSKIP | protein_coding | protein_coding | ENST00000556095 | 2 | 23812 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.382 | 0.577 | 125691 | 0 | 2 | 125693 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.983 | 52 | 76.1 | 0.683 | 0.00000393 | 911 |
Missense in Polyphen | 15 | 24.36 | 0.61576 | 295 | ||
Synonymous | -0.846 | 37 | 31.0 | 1.19 | 0.00000183 | 264 |
Loss of Function | 1.62 | 1 | 4.86 | 0.206 | 2.89e-7 | 61 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000900 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: A-kinase anchoring protein for GSK3B and PKA that regulates or facilitates their kinase activity towards their targets (PubMed:27484798, PubMed:25920809, PubMed:16981698). The ternary complex enhances Wnt-induced signaling by facilitating the GSK3B- and PKA-induced phosphorylation of beta-catenin leading to beta-catenin degradation and stabilization respectively (PubMed:27484798, PubMed:16981698). Upon cAMP activation, the ternary complex contributes to neuroprotection against oxidative stress-induced apoptosis by facilitating the PKA-induced phosphorylation of DML1 and PKA-induced inactivation of GSK3B (PubMed:25920809). During neurite outgrowth promotes neuron proliferation; while increases beta-catenin-induced transcriptional activity through GSK3B kinase activity inhibition, reduces N-cadherin level to promote cell cycle progression (PubMed:19830702). {ECO:0000269|PubMed:16981698, ECO:0000269|PubMed:19830702, ECO:0000269|PubMed:25920809, ECO:0000269|PubMed:27484798}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.04
Haploinsufficiency Scores
- pHI
- 0.215
- hipred
- N
- hipred_score
- 0.444
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Low |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Gskip
- Phenotype
- skeleton phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- negative regulation of protein kinase activity;intrinsic apoptotic signaling pathway in response to oxidative stress;regulation of Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein kinase inhibitor activity;protein binding;beta-catenin binding;protein kinase binding;protein kinase A regulatory subunit binding;protein kinase A binding